NATURAL PRODUCT RESEARCH AND DEVELOPMENT ›› 2016, Vol. 28 ›› Issue (6): 916-921. doi: 10.16333/j.1001-6880.2016.6.017

• Article • Previous Articles     Next Articles

Development and Preliminary Application of High Throughput Screening Model of α-Glycosidase Inhibitor from Microorganism

YU Cai-yun1,ZHAO Li-li2,ZHANG Jing-jing1,WEI Tao1*   

  1. 1 Beijing Key Laboratory of Bioactive Substances and Function Food,Beijing Union University,Beijing 100191,China; 2 Institute of Medicinal Biotechnology,Chinese Academy of Medical Sciences & Peking Union Medical College,Beijing 100050,China
  • Online:2016-06-30 Published:2017-01-17

Abstract: The α-glycosidase was extracted from the upper duodenum of Kunming mice.4-Nitrophenyl-α-D-glucopyranoside was used as substrate to establish a high throughput drug screening model of α-glycosidase inhibitor.A total of 2224 microbial fermentation extracts,including 1276 strains of actinomycetes and 132 strains of bacteria,were screened.23 positive samples were obtained,with a 1.03% positive rate at the first screening.The 23 strains were fermented and extracted for a second time,17 positive samples were obtained,with 3 bacterium and 13 actinomycetes.The positive rate was 0.74%.3 Positive samples were verified by α-glycosidase to have inhibitory effects higher than 75%.In conclusion,the developed α-glycosidase inhibitor high-throughput screening model had high practical value for developing new hypoglycemic drugs.

Key words: Alpha-glycosidase inhibitor, high-throughput screening model, microbial fermentation extract, Diabetes Mellitus

CLC Number: